Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003565502 | SCV004316011 | benign | not provided | 2024-08-13 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003565502 | SCV005411446 | uncertain significance | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | BS2 |
Genome |
RCV001825222 | SCV002074952 | not provided | X-linked dystonia-parkinsonism | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 10-06-2020 by Lab or GTR ID 239772. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Prevention |
RCV003923334 | SCV004738814 | likely benign | TAF1-related disorder | 2024-08-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |